MODIFI’s Post

Christian your commitment to natural remedies aligns perfectly with the evolving healthcare landscape.

#CPHI Here we come again! First time to present Accestra at one of the most innovative pharma events in North America. Raymond N. will share valuable insights and expertise on the topics of China Drug Master File (DMF). If you are attending the event on 7-9 May in Philadelphia, don't miss out on our presentation! More details in the poster below. Book a meeting with our expert at the event to learn more about China DMF recent updates! Look forward to seeing you there! #chinadrugmasterfile #chinadmf #api #excipient #pharmaceuticalpackaging #chinaregulatoryaffairs #chinadmfregistration

✨ Namaste Global Heads to CPHI North America: Bridging the Gap for Indian Healthcare in the US Market! ✨ We as Namaste Global will be attending CPHI North America, the premier pharmaceutical event, happening 07 – 09 May in Philadelphia! Our founder, 📢 Sanchit Sharma, and our team of 💊 scientific experts are eager to connect with industry leaders, explore the latest advancements in biopharma, and showcase how Namaste Global empowers Indian healthcare companies to seamlessly enter and thrive in the US market. Are you an Indian CDMO looking to expand your reach? CPHI provides the perfect platform to connect with potential US partners and unlock new growth opportunities. We understand the challenges CDMOs face in navigating the US market, and our team is here to help! At CPHI, we'll be discussing: ⭐ Strategies for Indian CDMOs to successfully enter the US market. ⭐ Building strategic partnerships with US pharmaceutical companies. ⭐ Leveraging Namaste Global's expertise to overcome regulatory hurdles and cultural differences. Connect with us! We'd love to discuss your specific needs and how Namaste Global can help you achieve your US expansion goals. Schedule your meet with us between May 7 – 9 by writing to us at info@namasteglobal.co or comment below. #CPHI #NorthAmerica #Pharma #CDMO #India #USA #Healthcare #MarketEntry #Partnerships

It's fantastic to see some footage from the 14th Clinical Biomarkers & CDx Summit Europe, which took place last month. One quote from the summit which particularly stood out: "The most exciting thing in the CDx space right now in Europe is IVDR... what is coming, what is changing, and the challenges ahead of us." This is why we've dedicated an entire conference to navigating regulatory hurdles, featuring perspectives from Europe, the US, and APAC, aiming to expedite patient access to safer, more efficacious drugs. Download the brochure here:https://ter.li/h1hbq2

Only two more weeks to go until one of the most important international trade fairs for the pharmaceutical industry, the @CPHI in Barcelona, opens its doors. Secure a one-on-one meeting with our experts from Schubert-Pharma and learn more about our tailored solutions for the pharmaceutical industry. 📅 October 24 – 26, 2023 📍 Barcelona, booth 3U49 Here are 𝗳𝗶𝘃𝗲 good reasons to visit our booth: 1. 𝗣𝗿𝗲𝗰𝗶𝘀𝗶𝗼𝗻 𝗶𝗻 𝗣𝗮𝗰𝗸𝗮𝗴𝗶𝗻𝗴: We ensure that every product is packaged with utmost accuracy. 2. 𝗩𝗲𝗿𝘀𝗮𝘁𝗶𝗹𝗶𝘁𝘆 𝗶𝗻 𝗦𝗼𝗹𝘂𝘁𝗶𝗼𝗻𝘀: We offer packaging solutions for various products, from vials, syringes and ampoules to BFS products, devices, and combination products. 3. 𝗜𝗻𝗻𝗼𝘃𝗮𝘁𝗶𝘃𝗲 𝗧𝗟𝗠 𝗧𝗲𝗰𝗵𝗻𝗼𝗹𝗼𝗴𝘆: The modular principle of our TLM technology allows for a wide range of applications tailored to unique client needs. 4. 𝗔𝗱𝘃𝗮𝗻𝗰𝗲𝗱 𝗥𝗼𝗯𝗼𝘁𝗶𝗰𝘀 𝗮𝗻𝗱 𝗦𝗼𝗳𝘁𝘄𝗮𝗿𝗲: Emphasis on using cutting-edge robotics and intelligent software for exceptional quality and safety. 5. 𝗣𝗿𝗼𝗱𝘂𝗰𝘁 𝗧𝗿𝗮𝗰𝗲𝗮𝗯𝗶𝗹𝗶𝘁𝘆: Ensuring that every product can be traced back through its production and packaging journey, increasing trust and transparency for end-users. Curious to learn how your company benefits from our packaging solutions? Well, then 𝗿𝗲𝗴𝗶𝘀𝘁𝗲𝗿 𝗳𝗼𝗿 𝗙𝗥𝗘𝗘 👇 Link: https://lnkd.in/e_bszDpu Code: FOCX2264 #SchubertPharma #CPHI #PackagingExcellence #PharmaceuticalIndustry

> CordenPharma CEO Dr. Michael Quirmbach is interviewed at CPHI Barcelona 2023 by Life Sciences Knowledge Hub about our kickoff of a €500 Million CapEx expansion program over the next 3 years in key areas such as small to large-scale peptides, oligonucleotides, Lipid NanoParticle (LNP) formulation, specialized lipid excipients, and new offerings for highly potent & oncology oral solid dosage manufacturing such as Bioavailability Enhancement. Additional topics include enhanced ESG & Sustainability Science-Based Target initiatives, green technologies such as Supercritical Fluid Chromatography (SFC) and continuous manufacturing, and key industry trends such as supply chain resilience & diversification. The interview finishes with CordenPharma's distinguishing strength as a CDMO, and how it centers around an expert global team and integrated end-to-end services from APIs to Drug Products that add real value to pharma & biotech customers' project journeys. #cphibarcelona #CordenPharma #peptides #oligos #lnps #lipids #osd #esg #greenmanufacturing #continuousmanufacturing #apis #drugproduct #drugmanufacturing #pharmaceuticals https://lnkd.in/e7TXQtiq

Throwback to PiVOT's Bio Asia-Taiwan experience last year where PiVOT proudly represented the Philippines as one of the 550 exhibitors from around 15 countries, all aiming to tap into the potential business opportunities within Taiwan's thriving biotech sector. PiVOT has come a long way since we attended the BIO Asia-Taiwan 2022 last year. With an impressive portfolio of 16 clinical trials, including 9 vaccine-related studies, PiVOT has successfully recruited over 40,000 patients despite only 3 years of operation. PiVOT’s extensive experience spans collaborations with foreign pharmaceutical companies, regional CROs, and global NGOs. This has paved the way for PiVOT's accomplishment of passing four inspections by the Philippine FDA, two inspections by the Chinese CFD, and three client audits. Additionally, PiVOT has been actively participating in renowned international conferences solidifying its global presence. As we eagerly anticipate Bio Asia-Taiwan happening next week, our team is thrilled to showcase our expertise and offerings in the bio and healthcare sectors. We look forward to engaging with industry leaders, forging new partnerships, and fostering the growth of the biotech industry. #pivotcro #BioAsiaTaiwan #BioTaiwan #clinicaltrials #clinicalresearch

Help us decide! We're planning our 2024 (non-therapy-area) congress attendance. Rank the following congresses in order of your interest: DIA, MAPS, ISMPP, Pharma USA. What others might we be missing? #medcomms #healthcaremarketing #scientificpublications #HCPengagement #helpusdecide #clinicaltrials

Exciting Updates from CPHI China 2024 As CPHI China 2024 concludes, heartfelt thanks go out to all involved - partners, sponsors, organizers, and participants. Your dedication and hard work ensured the event's success. Another successful year at CPHI - the leading global event uniting pharma professionals for over three decades! From fostering connections to inspiring partnerships, CPHI continues to champion innovation at the heart of the pharmaceutical industry. This year, our team had the privilege to attend the event held in the Shanghai China 2024. Our CEO  Dr. Santosh Joshi along with his team Mr. Sunil Bharti (Business Development Head) and Mr. Satyam Ghag, represented our company with enthusiasm and passion. They seized the opportunity to network, learn, and contribute valuable insights to the community. We believe in the power of collaboration and knowledge sharing. Our team not only gained valuable insights but also shared their own experiences, contributing to the collective growth of the industry. As we say goodbye to #CPHIChina 2024, We are now committed to staying connected with our industry peers. Let's continue to innovate, collaborate, and shape the future of pharma together! #CPHI #CPHIChina #China #pharma #Pharmaceuticals #clinical #clinicalreserch #Clinicaltrial #Clinical #pharmasource #drugs #drugsdevelopment #analysis #India #Indianpharma #medicine

Informa Markets in India is gearing up to host the 16th edition of the CPHI & PMEC India Expo, a premier event in the #SouthAsianpharmaceutical industry. Scheduled from November 28 to 30, 2023, at the #IndiaExpoCentre in Greater Noida, Delhi, this expo is expected to bring together more than 1,500 exhibitors and attract over 45,000 visitors from 150+ countries. Amidst #India’s pharmaceutical sector poised for substantial growth—projected to achieve a 13 percent CAGR and reach a market value of ₹8.5 lakh crores by 2028—this expo serves as a pivotal platform for global insights, #technology , and market trends, with a spotlight on the technology and ingredients sectors. The event aims to bridge the gap between industry elements, fostering direct engagement among key stakeholders including top executives, buyers, #manufacturers , #administrators , and #regulatory representatives. With a focus on innovative solutions and navigating economic uncertainties, the expo offers a forum for discussions and exploration of the evolving dynamics within #India’s pharmaceutical trade. Exhibitors are set to unveil cutting-edge advancements in AI-based quality control, state-of-the-art #technology , novel drug delivery systems, and sustainable packaging innovations. Renowned industry players such as Dr. Reddy’s Laboratories Ltd, Biocon Ltd, Glenmark Lifesciences Ltd, and others will be among the prominent #exhibitors showcasing their innovations and contributions to the #pharmaceuticallandscape. The event’s comprehensive approach aims to drive the industry forward, fostering collaborations and presenting unparalleled opportunities for networking, knowledge exchange, and business growth in the evolving pharmaceutical landscape of South Asia. #News #Healthnews #Medlr #Healthcare #Expo #Indianews